Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
HernandezAFGreenJBJanmohamedSAgostinoDGrangerRBJonesCBet alAlbiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (harmony outcomes): a double-blind, randomised placebo-controlled trial
Novartis is investing in expanding Pluvicto's label into pre-taxane prostate cancer (SPLASH trial submission pending), and developing next-generation RLT approaches targeting breast cancer and other tumour types positioning it to maintain leadership in the highest-growth oncology peptide segment
While most supplements and even anabolic steroids just make your existing muscle fibers bigger, IGF-1 LR3 can help create new ones through satellite cell activation
In MDA-MB-468 cells with low GLS1 expression, combined CB-839 with cisplatin does not show a significant synergistic antitumor effect (Hong et al., 2022)
